{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T22:09:41Z","timestamp":1648937381539},"reference-count":20,"publisher":"Georg Thieme Verlag KG","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1055\/a-1258-5429","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T22:31:01Z","timestamp":1634164261000},"page":"1337-1343","source":"Crossref","is-referenced-by-count":0,"title":["Morbus Basedow"],"prefix":"10.1055","volume":"146","author":[{"given":"Stephanie","family":"Allelein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,10,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1055\/s-0035-1559648","article-title":"Mechanisms of Action of TSHR Autoantibodies","volume":"47","author":"J Furmaniak","year":"2015","journal-title":"Horm Metab Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/cen.14072","article-title":"Changes in subtypes of overt thyrotoxicosis and hypothyroidism following iodine fortification","volume":"91","author":"M Petersen","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1055\/s-2007-978666","article-title":"Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation","volume":"32","author":"M Schott","year":"2000","journal-title":"Horm Metab Res"},{"key":"ref4","first-page":"489","article-title":"Clinical characteristics of subacute thyroiditis is different than it used to be \u2013 current state based on 15 years own material","volume":"39","author":"M Stasiak","year":"2019","journal-title":"Neuro Endocrinol Lett"},{"key":"ref5","volume-title":"Referenz Endokrinologie und Diabetologie","author":"S Diederich","year":"2020","edition":"1. Auflage."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association Guideline for the Management of Graves\u02bc Hyperthyroidism","volume":"7","author":"G J Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"CD003420","DOI":"10.1002\/14651858.CD003420","article-title":"Antithyroid drug regimen for treating Graves\u02bc hyperthyroidism","volume":"pub4","author":"P Abraham","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/cen.12949","article-title":"Treatment and management of thyroid storm: analysis of the nationwide surveys","volume":"84","author":"O Isozaki","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis","volume":"26","author":"D S Ross","year":"2016","journal-title":"Thyroid"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa636","article-title":"Methimazole Treatment and Acute Pancreatitis: Both Caution and Reassurance Are Needed","author":"L Bartalena","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1089\/thy.2019.0085","article-title":"The Long-Term Outcome of Treatment for Graves\u02bc Hyperthyroidism","volume":"29","author":"G Sjolin","year":"2019","journal-title":"Thyroid"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1089\/thy.2019.0132","article-title":"Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves\u02bc Disease: A Nationwide Population-Based Study","volume":"30","author":"J P Brito","year":"2020","journal-title":"Thyroid"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1530\/EJE-13-0811","article-title":"Long-term prognosis after medical treatment of Graves\u02bc disease in a northern Swedish population 2000\u20132010","volume":"170","author":"E Mohlin","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1055\/s-2004-814217","article-title":"Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves\u02bc disease","volume":"36","author":"M Schott","year":"2004","journal-title":"Horm Metab Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1089\/thy.2019.0180","article-title":"Increased Remission Rates After Long-Term Methimazole Therapy in Patients with Graves\u02bc Disease: Results of a Randomized Clinical Trial","volume":"29","author":"F Azizi","year":"2019","journal-title":"Thyroid"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/thy.2016.0457","article-title":"2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum","volume":"27","author":"E K Alexander","year":"2017","journal-title":"Thyroid"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11154-020-09615-z","article-title":"Impact of COVID-19 on the thyroid gland: an update","volume":"2020","author":"L Scappaticcio","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s40618-020-01366-7","article-title":"SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves\u02bc disease after COVID-19","volume":"43","author":"M Mateu-Salat","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s40618-020-01293-7","article-title":"Management of Graves\u02bc hyperthyroidism and orbitopathy in time of COVID-19 pandemic","volume":"43","author":"L Bartalena","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1210\/er.2018-00006","article-title":"Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints","volume":"40","author":"L S Chang","year":"2019","journal-title":"Endocr Rev"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1258-5429.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T22:31:52Z","timestamp":1634164312000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1258-5429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":20,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2021,10,13]]},"published-print":{"date-parts":[[2021,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1258-5429","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}